The Management of Intravenous Infiltration Injuries in Infants and Children
|
|
- Maria Welch
- 6 years ago
- Views:
Transcription
1 The Management of Intravenous Infiltration Injuries in Infants and Children Terry Treadwell, MD, FCS bstract The intravenous administration of fluids and medications is critical for the treatment of seriously ill patients. Unfortunately, especially in infants and children, fluid infiltration into the surrounding tissue can occur. Early recognition and prompt treatment usually limits the extent of tissue damage. Early treatment may include the injection or application of medication (eg, hyaluronidase, phentolamine, or nitroglycerin ointment) and appropriate dressings. Research to guide the care of more extensive extravasation injury remains limited. t the author s institution, the protocol of care for children and infants with extensive tissue damage and necrotic tissue consists of careful debridement followed by the use of oxidized regenerative cellulose (ORC)/collagen dressings and skin replacement if needed. Research to help clinicians develop evidence-based protocols of care for both minor and more severe intravenous fluid infiltration or extravasation injury is needed. Keywords: IV infiltration, infants, children, wounds, extravasation Index: Ostomy Wound Management 2012;58(7):40 44 Potential Conflicts of Interest: none disclosed The intravenous route of administering blood, fluid, and medications to patients is a relatively recent phenomenon that provides rapid effect of the fluid or medication without the problems of absorption from the gastrointestinal tract and the uncertainty of giving medication via the intramuscular route. 1 The first recorded intravenous administration of blood to man was done by Jean-aptiste Denis on June 15, ,3 Due to political issues and the fact that the different blood types and anticoagulation were not well understood, the transfusion of blood did not become acceptable until the early 20th century. The first intravenous administration of saline was performed in the 1830s, but it did not become common practice until the early 1900s. 4 Not until medication was sufficiently pure was intravenous administration considered reasonable. 1 Unfortunately, complications soon followed; most were found to be related to delivery of the fluid and/or medication into the subcutaneous tissues instead of the vein. Over a 5-year period at the author s institution, intravenous infiltration injuries were found to have occurred in 10% to 30% of pediatric patients receiving intravenous infusions; 55% of the injuries occurred in neonates (see Figure 1). 5 The high incidence of these injuries in young patients stimulated a review of these cases and resulted in the development of a treatment protocol now in use. Risk Factors Case studies 6,7 have shown several factors are important in the potential development of an intravenous infusion injury. The younger the patient, the more likely the injury is to occur; the smaller catheter size used for the infusion (the larger the gauge of the catheter) and the use of butterfly catheters (needles) are associated with a greater chance of extravasation of fluid and medication. ccording to several case studies, 5,6,8 children and neonates with darker skin are more likely to suffer from extravasation because of the difficulty visualizing the very small veins in this population. In addition, injury from extravasation of fluids and medications is directly related to the medication and/or fluid administered (see Table 1). lso, hyperosmolar fluids and fluids containing electrolytes are likely to cause tissue damage when leaked into the tissues, as are many antibiotics and chemotherapeutic agents. 5,6,9 s expected, vasopressors (common intravenous medications in these very young and very fragile patients) are caustic to the tissues when leaked out of the vein. 8 Treatment Considerations Early recognition. Obviously, early recognition to minimize fluid and/or medication volume deposited into the subcutaneous tissues is important to minimize the tissue damage. Routine evaluation of the catheter insertion site is Dr. Treadwell is Medical Director, Institute for dvanced Wound Care, aptist Medical Center, Montgomery, L. Please address correspondence to: Terry Treadwell, MD, FCS, Institute for dvanced Wound Care, aptist Medical Center, 2167 Normandie Drive, Montgomery, L 36111; tatread@aol.com. 40 ostomy wound management july
2 Intravenous infiltration injuries Table 1. Medications and fluids likely to cause tissue damage following extravasation 5,6,8 ll intravenously administered medications and fluids Hyperosmolar solutions (total parenteral nutrition solutions, hypertonic glucose, hypertonic saline) lood Electrolytes (calcium, potassium) Vasopressors (dopamine, dobutamine, norepinephrine, epinephrine) Mannitol Digoxin ll antibiotics (especially tetracyclines, penicillin, vancomycin) minophylline Phenytoin ll sedative-type medications (sodiumthiopental, diazepam, chlordiazepoxide) ll chemotherapeutic agents Figure 1. Intravenous infiltration injuries in infants.. Intravenous infiltration of saline on the scalp; Intravenous infiltration of dopamine infusion. Figure 2. Intravenous infiltration injury treated with collagenase applied once daily for 4 weeks;. efore treatment;. fter 4 weeks of treatment with collagenase. Ostomy Wound Management 2012;58(7):40 44 Key Points Infiltration of vesicant or nonvesicant intravenous solution or medication into the surrounding tissue is a potentially serious complication of intravenous therapy. Patients at both ends of the age continuum are at highest risk for this injury. Prevention, early recognition, and prompt treatment usually limits tissue damage, and these wounds will heal in a timely fashion. The author describes a protocol of care developed to address this complication. critical for the early recognition of the problem. Once the problem is noted, the infusion should be discontinued immediately and moved to another site if needed. If the catheter is still in the subcutaneous tissues, the author recommends aspirating through the catheter to remove as much residual fluid as possible. The catheter then is removed. Elevation. Elevating the limb can result in more extensive spreading of the toxic material through the tissue and is not recommended. 8 lthough this approach goes against current thinking, the author has observed less tissue damage. Temperature. Case studies 7 have shown the use of warm or cold compresses to be controversial. The conventional idea is that warm compresses cause vasodilatation in the tissues, increasing the blood flow and thus resulting in faster removal of the toxic material. Heat actually may cause more injury to the damaged tissues by increasing the tissue demands for oxygen. Heat is beneficial only for the treatment of extravasation of hypertonic saline solutions. Cold july 2012 ostomy wound management 41
3 Figure 3. Treatment of intravenous infiltration injury with ORC/collagen.. efore therapy in 26-week gestation baby at 1 day of age;. fter 2 weeks of therapy with ORC/collagen. Table 3. Injuries best treated with phentolamine or nitroglycerin ointment 11 Dopamine Dobutamine Epinephrine Norepinephrine Table 2. Injuries best treated with hyaluronidase 11 TPN solutions of all types Electrolyte infusions ntibiotics minophylline Manitol Chemotherapeutic agents including vinca alkaloids compresses often are thought beneficial by causing vasoconstriction and preventing the spread of the toxic material. However, the vasoconstrictive effect of cold causes the tissue to become ischemic and makes most infusion injuries worse. 10 Medications. ccording to a review of the literature, 11 certain medications have been found beneficial in extravasation injuries. 11 One is hyaluronidase, an enzyme that allows the infiltrated fluid to diffuse through the tissues. Its effects last 24 to 48 hours. The medication should be diluted to 15 units/ml; 1 ml is injected into the tissues either through the catheter, if still present, or subcutaneously. It is most effective if used within the first 2 hours post-infiltration, but has been found beneficial if given up to 12 hours after infiltration. 7,11 The injuries that respond well to hyaluronidase are listed in Table 2. Phentolamine is beneficial for use following infiltration of medications causing vasoconstriction. 11 This vasodilator improves blood flow to the area to facilitate removal of the toxic medication and to protect the damaged tissue. The dose is 0.1 to 0.2 mg/kg to a maximum of 10 mg given through the catheter or subcutaneously. It is effective up to 12 hours after the infiltration. 7,10 It should not be given to premature infants, and all patients should be monitored for hypotension and tachycardia. 10 The injuries best treated with phentolamine are listed in Table 3. Nitroglycerin also has been found to be beneficial following infiltration of medications causing vasoconstriction. 11 It also causes vasodilatation of local vessels, improving blood flow to the area and facilitating removal of the toxic medication and increasing the blood flow to the injured tissues. Only small amounts should be used, and care should be taken because of the possibility of hypotension and tachycardia. 5 The injuries best treated with nitroglycerin ointment are listed in Table 4. Dressings. The area of injury should be protected with a nonadherent dressing and followed closely. Many of these injuries will be self-limited and resolve with no further treatment. Debridement. Tissue necrosis can occur as a result of the tissue damage; in such cases, the author recommends using the enzymatic debriding agent collagenase to remove the eschar. In vivo research 12, and a review of the literature 13 have shown that collagenase does not damage normal tissue, making it a good treatment choice. lthough experience using this product in this age group is limited, the author has found it to be a useful and safe alternative for these patients (see Figure 2). In the author s experience, aggressive sharp debridement in these very small and delicate patients can result in more tissue damage. However, as the eschar loosens, sharp debridement can be used to completely remove only the necrotic tissue. If a significant amount of tissue has been lost, a practitioner familiar with children and neonates should be consulted for sharp debridement. Following removal of the eschar in wounds not requiring skin replacement, case studies 14 suggest the use of an oxidized regenerated cellulose (ORC)/collagen product can be beneficial. ORC/collagen is composed of 55% type 1 bovine collagen and 44% ORC. The collagen component has been shown in vitro 15 to provide structural support for cellular and capillary ingrowth and is capable of reducing proinflammatory cytokines and mediators and proteases. The product dissolves into the wound bed within 2 to 3 days, making the dressing changes easy and comfortable for these fragile patients (see Figure 3). Other collagen dressings and nonadherent dressings can be considered. 42 ostomy wound management july
4 Intravenous infiltration injuries C D Figure 4. Treatment of intravenous infiltration injury with bilayered tissue-engineered skin.. Injury due to dopamine infiltration: before debridement;. Post debridement; C. pplication of bilayered, tissue-engineered skin; D. Healed 3 weeks post-application of bilayered, tissue-engineered skin. Silver-containing dressings should be used with great care in children and neonates; while dressings releasing very low levels of silver have been found in pediatric case studies to be well-tolerated and not damage the cells in the wound bed, toxicity of silver dressings, a growing concern in children, has resulted in systemic serum levels 800 times normal 18,19 and their use should be avoided. Skin replacement. If the tissue defects are large, closure may be difficult and require skin replacement. Skin grafting in very young children is fraught with hazard and produces another wound just as difficult to close as the original lesion. The author and other clinicians have found that the use of cell-containing tissue-engineered skin products that have been approved for use in chronic wounds can have a great benefit in these patients (lthough these products are only approved for use with diabetic foot ulcers, pligraf [Organogenesis, Inc, Canton, M] has approval for humanitarian use in infants and children with epidemolysis bullosa.) These products are designed to provide healthy cells to the wound bed to stimulate and accelerate healing (see Figure 4). Conclusion Extravasation injury from intravenous fluid is a potentially serious complication in infants and children. When prevention efforts fail, early recognition and appropriate treatment are essential to minimize the extent of the injury. Most injuries will heal spontaneously without complications. Per opinion and research, 10 having a clinical practice guideline in place before injuries occur is critical to encourage early recognition and immediate and informed treatment. The guideline used by the Institute for dvanced Wound Care at aptist Medical Center, Montgomery, L, (see Table 4) has worked well in the author s center; use by others is pending. Fortunately, technology has provided treatment options for the patients with significant injuries that have been useful in the author s clinical practice. dditional work will be required to accomplish earlier recognition of these injuries, if possible, and continued research with various wound dressings will be required to find the optimal treatment of wounds in this age group. n References 1. Treadwell T. Intramuscular injection site injuries masquerading as pressure ulcers. WOUNDS. 2003;15(9): rown H. Jean Denis and the Transfusion of lood, Paris, Isis rown Harcourt;1947;39z; Tucker H. lood Work: Tale of Medicine and Murder in the Scientific Revolution. New York, NY: W.W. Norton and Co;2011: Weatherhill T. Case of malignant cholera in which four hundred and eighty ounces of fluid were injected into the veins with success. Lancet. 1832;18(470): Treadwell T, Fuentes ML, Walker D, Mara L. The pproach to Injuries Due to Extravasation of Intravenous Medications and Fluids. Poster presented at the Symposium on dvanced Wound Care. Dallas, TX. pril Thomas D, Rowe HN, Keats J, Morgan RJH. The Management of Extravastion Injury in Neonates. vailable at: com/1997/october/neonates/neonatepaper.html. ccessed June 11, Hastings-Tolsma MT, Yucha C, Tompkins J, Robson L, Szevereny N. Effect of warm and cold applications on the resolution of IV infiltrations. Res Nurs Health. 1993;16: Yucha C, Hastings-Tolsma M, Szeverenyi NM. Effect of elevation on intravenous extravasations. J Intraven Nurs. 1994;17: Larson DL. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg. 1985;75: Montgomery L, udreau GK. Implementing a clinical practice guideline to improve pediatric intravenous infiltration outcomes. CN Clin july 2012 ostomy wound management 43
5 Table 4. Institute for dvanced Wound Care Guidelines for the Treatment of Intravenous Extravasation Injuries 5 Discontinue the infusion If catheter is out of the vein, aspirate to remove as much residual fluid as possible Remove catheter Elevation of limb is not needed Use of warm or cold compresses controversial a. Only benefit of warm compress is on hypertonic saline infiltration b. Heat may cause further damage with chemotherapy infiltration c. Vinca alkaloid infiltration made worse by cold compresses Consider infiltration of medications to relieve tissue damage a. Hyaluronidase is an enzyme that temporarily decreases viscosity of the ground substance and allows the infiltrated fluid to diffuse through the tissues. The increased permeability is transient lasting only 24 to 48 hours. Dilute to 15 units/ ml, then inject 1 ml into tissues either through the catheter, if still present, or subcutaneously. It is most effective if used with the first 2 hours post infiltration but is still beneficial if given up to 12 hours after infiltration b. Phentolamine for use following infiltration of vasoconstrictor products. It is a vasodilator that inhibits vasoconstriction caused by the infiltrate and improves blood flow to the area. vailable in 5 mg/1 ml vials and should be diluted to 5 to 10 ml. The dose is mg/kg to a maximum of 10 mg given through the catheter or subcutaneously. It is effective up to 12 hours after the infiltration. It should not be given to premature infants, and all patients should be monitored for hypotension and tachycardia c. Nitroglycerin ointment for use following infiltration of vasoconstrictor products. It is absorbed through the skin and causes vasodilatation of local vessels improving blood flow to the area. Care should be taken in its use because its absorption can result in systemic effects, including hypotension and tachycardia. The amount of nitroglycerin ointment required to cause a systemic effect varies from patient to patient, so great care should be taken in its use, especially in unstable patients. Cover the injured area with a protective dressing and change daily noting any changes in the tissue If necrosis of the skin at the infiltration site occurs, apply a small amount of collagenase to the area (enough to cover the eschar with a thin coat) and cover with a moist dressing. Change the dressing twice daily Consult physician for decision about sharp debridement of necrotic tissue Following debridement or enzymatic removal of the necrotic tissue, moist wound care with collagenase, ORC/collagen products, nonadherent dressing, or similar dressings should be continued. The wound should be monitored on a regular basis to evaluate for healing, worsening, or infection dditional wound treatment and coverage will be determined by the consulting physician Issues. 1996;7: Wright. Reducing infusion failure a pharmacologic approach. review. J Intravenous Nurs. 1996;19: Riley KN, Herman IM. Collagenase promotes the cellular responses to injury and wound healing in vivo. J urns Wounds. 2005;4(8): Falanga V. Wound bed preparation and the role of enzymes: a case for multiple actions of therapeutic agents. WOUNDS. 2007;14(2): Treadwell T, Walker D, Mara L. The Treatment of Extravasation of Intravenous Medications and Fluids in Neonates and Children with ORC/Collagen/Silver (Prisma ). Poster presented at the First International Symposium on Pediatric Wound Care. Rome, Italy. October Gregory SJ, oothman S, Cullen M. Effect of ORC/Collagen Matrix Containing Silver on Inflammatory Mediators Elevated in Response to acterial Endotoxins. bstract presented at 15th nnual Meeting of the European Tissue Repair Society, Stuttgart, Germany, September 14-17, (Published in Wound Rep Reg. 2006;14:17) 16. Poon VK, urd. In vitro cytotoxicity of silver: implication for clinical wound care. urns. 2004;30: Treadwell T, Fuentes ML, Walker D. Treatment of second-degree burns with dehydrated, decellularized amniotic membrane (iovance) versus a silver dressing (cticoat). Wound Rep Reg. 2008;16: Denyer J. Safe Topical ntimicrobial Use in Paediatric Wounds. Oral presentation at the First International Symposium on Pediatric Wound Care. Rome, Italy. October 28, Denyer J. Infection management: antimicrobial management for children with epidermolysis bullosa. rit J Nurs. 2012;3(suppl): Treadwell T, Walker D, Dixon M, Nicholson. The Use of i-layered Tissue Engineered Skin in the Treatment of Infants and Children, Oral and Poster Presentation at the First International Symposium on Pediatric Wound Care. Rome, Italy. October Charles C, Kato T, Tzakis G, Miller N, Kirsner RS. Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation. Dermatol Surg. 2004;30: Drosou, Kirsner RS, Kato T, Mittal N, l-niami, Miller, Tzakis G. Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation. J m cad Dermatol. 2005;52: Falabella F, Schachner LS, Valencia IC, Eaglstein WH. The use of tissue-engineered skin (pligraf) to treat a newborn with epidermolysis bullosa. rch Dermatol. 1999;135: ostomy wound management july
Extravasation Management of Non- Chemotherapeutic Agents
Extravasation Management of Non- Chemotherapeutic Agents Sarah M. Martin, PharmD, MBA St John Medical Center Tulsa, OK Objectives Review non-chemotherapeutic agents that can cause extravasation Explain
More informationRisk factors and drugs/infusion commonly associated with tissue damage include: Extreme Prematurity Dextrose greater than 12.
Neonatal Intensive Care Unit Clinical Guideline Extravasation injuries Extravasation is defined as the inadvertent leakage of infused fluid into the surrounding tissue. The resultant damage to tissue can
More informationYorkshire & Humber Neonatal ODN (South) Clinical Guideline
Yorkshire & Humber Neonatal ODN (South) Clinical Guideline Title: Extravasation Injuries in Neonates Author: Dr Pauline Adiotomre, Lynn Elliot Date Written: March 2005, Reviewed July 2018 by Dr Pauline
More informationLower Extremity Wound Evaluation and Treatment
Lower Extremity Wound Evaluation and Treatment Boni-Jo Silbernagel, DPM Describe effective lower extremity wound evaluation and treatment. Discuss changes in theories of treatment in wound care and implications
More informationThe Georgetown Team Approach to Diabetic Limb Salvage: 2013
The Georgetown Team Approach to Diabetic Limb Salvage: 2013 John S. Steinberg, DPM FACFAS Associate Professor, Department of Plastic Surgery Georgetown University School of Medicine Disclosures: None Need
More informationDressings do not heal wounds properly selected dressings enhance the body s ability to heal the wound. Progression Towards Healing
Dressings in Wound Care: They Do Matter John S. Steinberg, DPM FACFAS Associate Professor, Department of Plastic Surgery Georgetown University School of Medicine Dressings do not heal wounds properly selected
More informationPharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration
Pharmaceutics I صيدالنيات 1 Unit 2 Route of Drug Administration 1 Routs of Drug administration The possible routes of drug entry into the body may be divided into two classes: Parenteral Rout Enteral Rout
More informationParenteral Products. By: Howida Kamal, Ph.D
Parenteral Products By: Howida Kamal, Ph.D Dosage forms Route of administration Enteral INTO Parenteral ONTO Topical Dosage forms Physical form Solid Liquid Semi-solid Powder Granules Tablets Capsules
More informationGalen ( A.D) Advanced Wound Dressing
Galen (120-201A.D) Advanced Wound Dressing Wounds heal optimally in a moist environment นพ.เก งกาจ ว น ยโกศล Wound assessment Ideal wound dressing Type of wound Clinical appearance Wound location Measurement
More informationExtravasation injuries. Amendments Date Page(s) Comments Approved by 03/16 ALL Completely updated guideline
Note: Guidance comments are written in italics Extravasation injuries Amendments Date Page(s) Comments Approved by 03/16 ALL Completely updated guideline Compiled by: In Consultation with: Ratified by:
More informationAdvancing the science of wound bed preparation
Advancing the science of wound bed preparation How Drawtex wound dressing works LevaFiber Technology provides three different types of action. Mechanisms of Action Capillary Action Hydroconductive Action
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More informationClinical Policy: EpiFix Wound Treatment
Clinical Policy: Reference Number: PA.CP.MP.140 Effective Date: 03/18 Last Review Date: 04/18 Coding Implications Revision Log Description EpiFix (MiMedx Group) is dehydrated human amniotic tissue that
More informationTOO MANY DRESSING CHOICES!!!! WOUND CARE MANAGEMENT AND PRODUCTS. Should Your Practice Dispense Wound Care Supplies? Pros:
WOUND CARE MANAGEMENT AND PRODUCTS Animesh Bhatia DPM, CWS, FAPWCA Board Certified Wound Specialist Diplomate, American Academy of Wound Management Fellow, American Professional Wound Care Association
More informationSmart Solutions for Serious Wounds. An advanced bilayer dermal regeneration matrix FDA approved for the treatment of diabetic foot ulcers.
Smart Solutions for Serious Wounds An advanced bilayer dermal regeneration matrix FDA approved for the treatment of diabetic foot ulcers. A New Approach to Diabetic Foot Ulcer Care Supported by Over Two
More informationWOUND CARE UPDATE. -Commonly Used Skin Substitute Products For Wound. -Total Contact Casting. Jack W. Hutter DPM, FACFAS, C. ped.
WOUND CARE UPDATE -Commonly Used Skin Substitute Products For Wound Closure -Total Contact Casting Jack W. Hutter DPM, FACFAS, C. ped. Commonly Used Skin Substitute Products for Wound Closure why are they
More informationAppropriate Dressing Selection For Treating Wounds
Appropriate Dressing Selection For Treating Wounds Criteria to Consider for an IDEAL DRESSING Exudate Management Be able to provide for moist wound healing by absorbing exudate or adding moisture Secure
More informationInteresting Case Series. Skin Grafting in Pyoderma Gangrenosum
Interesting Case Series Skin Grafting in Pyoderma Gangrenosum Marco Romanelli, MD, PhD, Agata Janowska, MD, Teresa Oranges, MD, and Valentina Dini, MD, PhD Department of Dermatology, University of Pisa,
More informationMean percent reduction in ulcer area from baseline at six weeks 62 % SANTYL Ointment + supportive care* + sharp debridement 1 (P<0.
Evaluating two common adjuncts to sharp debridement in the treatment of diabetic foot ulcers Mean percent reduction in ulcer area from baseline at six weeks 62 % 40 % SANTYL Ointment + supportive care*
More information8/20/12. Discuss the importance of thermoregulation in the neonate.
Sharon Rush MSN NNP-BC Discuss the importance of thermoregulation in the neonate. To maintain correct body temperature range in order to: Reduce oxygen consumption Reduce calorie expenditure Maximize metabolic
More information1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown
Medical-Surgical Nursing Care Second Edition Karen Burke Priscilla LeMone Elaine Mohn-Brown Chapter 46 Caring for Clients with Burns Types of Burns Thermal Dry heat flame Moist heat steam or hot liquid
More informationNURSING PRACTICE GUIDELINES
NURSING PRACTICE GUIDELINES ADMINISTRATION OF SUBCUTANEOUS FLUIDS INTRODUCTION The infusion of a solution into the subcutaneous tissues is called hypodermoclysis. The subcutaneous compartment (hypodermis)
More informationAdjunctive Therapies: The Use of Skin Substitutes and Growth Factors in Venous Leg Ulceration (VLU)
Adjunctive Therapies: The Use of Skin Substitutes and Growth Factors in Venous Leg Ulceration (VLU) Sami Khan, MD FACS Associate Professor of Surgery Division of Plastic and Reconstructive Surgery SUNY-Stony
More informationUnderstanding and Managing
Understanding and Managing MM s in Wound Bed Brock Liden DM, ABM, FAWCA Learning Objectives Review the four sequential phases of normal wound healing and recognize the BENEFICIAL effects of CONTROLLED
More informationDEBRIDEMENT. Professor Donald G. MacLellan Executive Director Health Education & Management Innovations
DEBRIDEMENT Professor Donald G. MacLellan Executive Director Health Education & Management Innovations DEBRIDEMENT Principles - CSD Methods of Debridement Biopsy options PRINCIPLES OF WOUND MANAGEMENT
More information-> Education -> Excellence
Quality Conference 5/2557 Extravasations: Event -> Education -> Excellence รศ.นพ. รว ศ เร องตระก ล สาขาว ชาก มารศ ลยศาสตร ภาควชาศลยศาสตร Extravasations: Event 1. Thrombophlebitis - superficial vein 2.
More informationIV Fluids Nursing B23 Objectives Serum Osmolality 275 to 295 Isotonic
1 IV Fluids Nursing B23 2 Objectives 3 Serum Osmolality Serum osmolality solute concentration of a solution Higher osmolality means greater pulling power for water Normal serum osmolality is 275 to 295
More informationApplication Guide for Full-Thickness Wounds
Application Guide for Full-Thickness Wounds PriMatrix Dermal Repair Scaffold PriMatrix Ag Antimicrobial Dermal Repair Scaffold Application Guide for Full Thickness Wounds PriMatrix is a unique dermal repair
More informationNorepinephrine (Levophed )
Norepinephrine (Levophed ) Scope C3IFT CCT Generic Name: Norepinephrine Trade Name: Levophed Chemical Class: Therapeutic Class: Actions: Pharmacokinetics: Vasopressor Vasopressor Mechanism of Action: Norepinephrine
More informationWound Management. E. Foy White-Chu, MD, CWSP
Wound Management E. Foy White-Chu, MD, CWSP E. Foy White-Chu, MD, CWSP Assistant Professor, OHSU Wound Medical Director, VAPORHCS List the Four Principles of Wound Bed Preparation Determine safe debridement
More informationConsider the possibility of pressure ulcer development
Douglas Fronzaglia II, DO, MS LECOM Institute for Successful Aging LECOM Institute for Advanced Wound Care and Hyperbaric Medicine Consider the possibility of pressure ulcer development 1 Identify ulcer
More informationVeins that are firm to
Intravenous cannulation is a technique in which a cannula is placed inside a vein to provide venous access. Venous access allows sampling of blood as well as administration of fluids, medications, parenteral
More informationAssessment & Management of Wounds in primary practice.
Assessment & Management of Wounds in primary practice. Nutrition Successful wound management depends on appropriate nutritional support. Poor nutrition is recognised as one of the major causes of poor
More informationCASE 1: TYPE-II DIABETIC FOOT ULCER
CASE 1: TYPE-II DIABETIC FOOT ULCER DIABETIC FOOT ULCER 48 YEAR-OLD MALE Mr. C., was a 48-year old man with a history of Type-II diabetes over the past 6 years. The current foot ulcer with corresponding
More informationTreatment for diltiazem extravasation
Treatment for diltiazem extravasation The Borg System is 100 % Treatment for diltiazem extravasation Start studying Extravasation drugs. Learn vocabulary, terms, and more with flashcards, games, and other
More informationPatient Care Information
Patient Care Information A Guide to Healing Diabetic Foot Ulcers Questions? Contact us: Clinician: Phone #: In case of emergency, dial 9-1-1 Dermal Regeneration Matrix Overview Diabetic foot ulcers are
More informationChapter 16 IV Flow Rates. Name three reasons why you think a person may need fluid replacement, IV fluids.
Chapter 16 IV Flow Rates Name three reasons why you think a person may need fluid replacement, IV fluids. NPO Dehydration Deliver medication Nutrition Deliver blood products 1 Chapter 16 Intravenous Flow
More informationSuccessful IV Starts Revised February 2014
Successful IV Starts Revised February 2014 Why Intravenous Therapy? Used for access to the body s circulation Indications: Administer fluids, blood, medications, and nutrition Obtain laboratory specimens
More informationA Pilot Study of Oxygen Therapy for Acute Leg Ulcers
A Pilot Study of Oxygen Therapy for Acute Leg Ulcers Background: The concept of increasing the oxygen concentration in healing wounds developed originally with hyperbaric oxygen therapy and from the fact
More informationThe Proven Multifunctional Dressing
The Proven Multifunctional Dressing belongs to an innovative class of multifunctional wound care dressings. dressings effectively cleanse, fill, absorb and moisten wounds throughout the healing continuum.
More informationExudate in the early stages of wound healing
Products & technology Wound management with the Biatain Silicone foam dressing: A multicentre product evaluation Authors: Hugues Cartier, Simon Barrett, Karen Campbell, Jan Forster, Mike Schmalzbauer,
More informationINTRODUCTION TO WOUND DRESSINGS
WOUND CARE INTRODUCTION TO WOUND DRESSINGS JEC 2017 Wound Care Successfully completed specialized skills training in Wound Management. WOUND CONDITIONS & SYMBOLS BY COLOURS Yellow Black Necrotic tissue
More informationChapter 64 Administration of Injectable Medications
Chapter 64 Administration of Injectable Medications Injectable Medications Injection or intravenous (IV) infusion More invasive than administration by mouth, rectum, or through the skin Common methods
More informationSkin Integrity and Wound Care
Skin Integrity and Wound Care By Dr. Amer Hasanien & Dr. Ali Saleh Skin Integrity and Wound Care Skin integrity: the presence of normal Skin & Uninterrupted skin layers by wounds. Factors affecting appearance
More informationRegenerative Tissue Matrix in Treatment of Wounds
Regenerative Tissue Matrix in Treatment of Wounds Learning Objectives Differentiate between reparative and regenerative healing Review surgical techniques for applying a regenerative tissue scaffold to
More informationFor the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA
For the use of only Oncologist or a Cancer Hospital or a laboratory Doxorubicin Hydrochloride Liposome Injection 2 mg/ml KEMODOXA COMPOSITION Each ml contains: Doxorubicin Hydrochloride IP...2 mg Water
More informationVACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur
VACUUM ASSISTED CLOSURE (V.A.C.) THERAPY: Mr. Ismazizi Zaharudin Jabatan pembedahan Am Hospital Kuala Lumpur Learning Objectives Define Negative Pressure Wound Therapy (NPWT) Discuss guidelines for the
More informationIV Fluids. Nursing B23. Objectives. Serum Osmolality
IV Fluids Nursing B23 Objectives Discuss the purpose of IV Discuss nursing interventions in IV therapy Identify complications of IV therapy Differentiate between peripheral line, central line, and PICC
More informationTitrating Critical Care Medications
Titrating Critical Care Medications Chad Johnson, MSN (NED), RN, CNCC(C), CNS-cc Clinical Nurse Specialist: Critical Care and Neurosurgical Services E-mail: johnsoc@tbh.net Copyright 2017 1 Learning Objectives
More informationEvaluation of the Use of a Silver Collagen Amorphous Gel in the Healing of Post Surgical and Dehisced Lesions
Evaluation of the Use of a Silver Collagen Amorphous Gel in the Healing of Post Surgical and Dehisced Lesions Presented by: Kathryn Khandaker, RN, BSN, CWCN and Deanna Sue Kohl, RN, BSN, CWOCN, CFCN Introduction:
More informationClinical. Summaries. 3M Tegaderm Matrix Matrix Dressing. Delayed wound healing: A major clinical problem
3M Tegaderm Matrix Matrix Dressing Clinical Summaries Delayed wound healing: A major clinical problem Chronic wounds have been defined as those that fail to progress through a normal, orderly, and timely
More informationIV Drug Delivery Systems used in Cancer Care
IV Drug Delivery Systems used in Cancer Care Cheri Constantino-Shor, RN, MSN, CRNI Seattle Cancer Care Alliance Nursing Staff Development Coordinator Presentation Objective Describe drug delivery devices
More informationULCERS 1/12/ million diabetics in the US (2012) Reamputation Rate 26.7% at 1 year 48.3% at 3 years 60.7% at 5 years
Jay Christensen D.P.M Advanced Foot and Ankle of Wisconsin 2-4% of the population at any given time will have ulcers 0.06-0.20% of the total population Average age of patients 70 years increased as more
More informationHEAT STROKE. Lindsay VaughLindsay Vaughn, DVM, DACVECCDVM, DACVECC
HEAT STROKE Lindsay VaughLindsay Vaughn, DVM, DACVECCDVM, DACVECC Heat Stroke More Preventable Than Treatable Heat Stroke A form of hyperthermia associated with a systemic inflammatory response leading
More informationANNA DROSOU, M.D. Pearland Dermatology Shadow Creek Parkway, Suite 340 Tel: Fax:
EDUCATION June 2013 July 2014 July 1, 2003 June 2006 July 2, 2002- June 30, 2003 February, 2001 June 2002 January 2000 January 2001 February 1995 January 1997 Procedural Dermatology Fellow Methodist Hospital
More informationYour guide to wound debridement and assessment. Michelle Greenwood. Lorraine Grothier. Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust
Your guide to wound debridement and assessment Michelle Greenwood Lead Nurse, Tissue Viability, Walsall Healthcare NHS Trust Lorraine Grothier Clinical Nurse Specialist, Tissue Viability, Central Essex
More informationIntravenous Infusions
Intravenous Infusions 1) An IV insulin infusion can be used for patients: a) with out of control diabetes b) with DKA (Diabetic Ketoacidosis) c) after a heart attack 2) Hyperglycemia is an adaptive response
More informationSafety of Peripheral Intravenous Administration of Vasoactive Medication
ORIGINAL RESEARCH Safety of Peripheral Intravenous Administration of Vasoactive Medication Jose Cardenas-Garcia, MD 1 *, Karen F. Schaub, BS 1, Yuly G. Belchikov, PharmD 2, Mangala Narasimhan, DO 1, Seth
More informationMulti-Center Clinical Results with PluroGel PSSD in Chronic Wounds
Multi-Center Clinical Results with PluroGel PSSD in Chronic Wounds Presented at a Satellite Symposium during the European Wound Management Association (EWMA) 2012 24 May 2012 Vienna, Austria Multi-Center
More informationVascular Disorders of the Hand Self-Assessment. Hand Vascular Disorders
Vascular Disorders of the Hand Self-Assessment 1. The patency rate of repairing a radial artery laceration with an intact palmar arch using modern microsurgical techniques is: A. 20% B. 40% C. 60% D. 80%
More informationThe VERSAJET II Hydrosurgery System
Precise Excision The VERSAJET II Hydrosurgery System The VERSAJET II Hydrosurgery System The VERSAJET II system enables a surgeon to precisely select, excise and evacuate nonviable tissue, bacteria and
More informationThe High-Flow Port Designed & Indicated for Apheresis
The High-Flow Port Designed & Indicated for Apheresis Advancing Lives and the Delivery of Health Care Bard is proud to introduce the first and only high-flow, power-injectable port designed and indicated
More informationWound Care in the Community. Lisa Sutherland MSc Tissue Viability Senior Lead Ipswich Hospital & Community NHS Trusts
Wound Care in the Community Lisa Sutherland MSc Tissue Viability Senior Lead Ipswich Hospital & Community NHS Trusts What are the key elements? What is the patient s goal or aim for the wound? What are
More informationInjection Techniques Principles and Practice. Introduction. Learning Objectives 5/18/2015. Richard E. Castillo, OD, DO
Injection Techniques Principles and Practice Richard E. Castillo, OD, DO Administering injections is considered a routine clinic activity Safety demands knowledge of: Anatomy & Physiology Pharmacology
More informationTaking the shock factor out of shock
Taking the shock factor out of shock Julie Antonellis, BS, LVT, VTS (ECC) Northern Virginia Regional Director for the VALVT Technician Supervisor VCA Animal Emergency Critical Care Business owner Antonellis
More informationCARE OF THE NEONATE: ITS ALL ABOUT THE SKIN. Katherine Kunkel, MSN, RNC-NIC, WCC
CARE OF THE NEONATE: ITS ALL ABOUT THE SKIN Katherine Kunkel, MSN, RNC-NIC, WCC Learning Objectives Recognize what are risk factors for the neonate within the intensive care unit. Understand the physiology
More informationThe Power of a Hydroconductive Wound Dressing with LevaFiber Technology
The Power of a Hydroconductive Wound Dressing with LevaFiber Technology The first step in healing a chronic wound is to detoxify it by removing slough, necrotic tissue, exudate and bacteria, while keeping
More informationCase study: A targeted approach to healing complex wounds using the geko device.
Case study: A targeted approach to healing complex wounds using the geko device. Authors: Mr Sameh Dimitri Consultant Vascular and Endovascular Surgeon MSc FRCS (Eng Edin) Nikki Pavey Physiotherapist at
More informationAppropriate use of silver dressings
Appropriate use of silver dressings David Keast, Center Director, Aging Rehabilitation and Geriatric Care Research Centre, St Joseph s Parkwood Hospital, London, Ontario, Canada Role of antimicrobial dressings
More informationOriginal Article Tissue engineered skin for diabetic foot ulcers: a meta-analysis
Int J Clin Exp Med 2015;8(10):18191-18196 www.ijcem.com /ISSN:1940-5901/IJCEM0014309 Original Article Tissue engineered skin for diabetic foot ulcers: a meta-analysis Xuedong Li 1, Geliang Xu 2, Jianqiu
More information3M Tegaderm Matrix Matrix Dressing. Matrix. Your questions answered
3M Tegaderm Matrix Matrix Dressing Matrix Your questions answered 3M Tegaderm Matrix Matrix Dressing Frequently Asked Questions What is Tegaderm Matrix? Matrix is a wound dressing impregnated with polyhydrated
More information5 Million neonatal deaths each year worldwide. 20% caused by neonatal asphyxia. Improvement of the outcome of 1 million newborns every year
1 5 Million neonatal deaths each year worldwide 20% caused by neonatal asphyxia Improvement of the outcome of 1 million newborns every year International Liaison Committee on Resuscitation (ILCOR) American
More informationThe Reverse Galeal Hinge Flap: Another Valuable Technique in the Repair of Scalp
TITLE PAGE TITLE: The Reverse Galeal Hinge Flap: Another Valuable Technique in the Repair of Scalp Defects Extending to the Calvarium AUTHORS: Lam, Thomas, BA; Indiana University School of Medicine Miletta,
More informationPhoto Diagnosis. Case 1 The upper lip of this three-year-old boy became swollen and itchy an hour after he had ingested some peanuts.
An illustrated quiz on problems seen in everyday practice Case 1 The upper lip of this three-year-old boy became swollen and itchy an hour after he had ingested some peanuts. 2. What is the treatment?
More informationSAMPLE. HLTEN406A Undertake basic wound care. Learner resource. HLT07 Health Training Package. Version 2
HLT07 Health Training Package HLTEN406A Undertake basic wound care Learner resource Version 2 Training and Education Support Industry Skills Unit Meadowbank Acknowledgments The TAFE NSW Training and Education
More informationSHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function
SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may
More informationPediatric Sepsis Treatment:
Disclosures Pediatric Sepsis Treatment: (treat) Early & (reevaluate) Often None June 11, 2018 Leslie Dervan, MD MS Pacific Northwest Sepsis Conference 1 Agenda Sepsis: pathophysiology at-a-glance Pediatric
More informationManagement of Complex Wounds with Vacuum Assisted Closure
Management of Complex Wounds with Vacuum Assisted Closure Wendy McInnes Vascular / Wound Nurse Practitioner The Queen Elizabeth Hospital, Adelaide, South Australia Treasurer ANZSVN wendy.mcinnes@health.sa.gov.au
More informationAdvancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis
Advancing Lives and the Delivery of Health Care The High-Flow Port Designed for Apheresis Optimized for Long Device Life Bench Tested up to 1,000 Accesses 1 Bard is proud to introduce the first and only
More informationPACKAGE INSERT CALCIUM GLUCONATE INJECTION, USP 10% Electrolyte Replenisher mosmol/ml 680 mosmol/l Ca meq/ml ph
CALCIUM GLUCONATE INJECTION, USP 10% Electrolyte Replenisher 0.68 mosmol/ml 680 mosmol/l Ca ++ 0.465 meq/ml ph 6.0 8.2 DESCRIPTION Calcium Gluconate Injection, USP is a sterile, nonpyrogenic supersaturated
More information- Conclusion: This study confirmed the very good acceptability and efficacy of Urgotul in the treatment of skin lesions in patients with EB.
www.journalofwoundcare.com Using Urgotul dressing for the management of epidermolysis bullosa skin lesions VOL 14, NO 10, November 2005 Objective: To evaluate the acceptability, tolerance and efficacy
More informationUnderstanding the pediatric patient and basics of pediatric emergencies. Dr. Alenka Hrovat Vernik DrVetMed PhD MRCVS
Understanding the pediatric patient and basics of pediatric emergencies Dr. Alenka Hrovat Vernik DrVetMed PhD MRCVS Stages of development Neonatal period - from birth till 3 rd -4 th week Weaning period
More informationPEDIATRIC SKILLED NURSING POLICY AND PROCEDURE MANUAL. Sample Home Health Agency
2019 PEDIATRIC SKILLED NURSING POLICY AND PROCEDURE MANUAL Sample Home Health Agency Pediatric Nursing is a nursing specialty that is provided to children in their places of residence. Because of this
More informationExtravasation guidelines Implementation Toolkit
Extravasation guidelines 2007 Guidelines Implementation Toolkit Contents Extravasation guidelines 2007 Introduction to the Extravasation guidelines Introduction 4 Overall Goal 4 Specific Targets and Aims
More informationCarboplatin / Liposomal Doxorubicin CARBO/CAELYX Gynaecological Cancer
Systemic Anti Cancer Treatment Protocol Carboplatin / CARBO/CAELYX Gynaecological Cancer PROCTOCOL REF: MPHAGYNCCX (Version No: 1.0) Approved for use in: Advanced ovarian cancer in women who have progressed
More informationMORPHINE ADMINISTRATION
Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction
More informationSHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital
SHOCK Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Definition Shock is an acute, complex state of circulatory dysfunction
More informationIntegra. Tissue Technologies. Limit uncertainty with a leader in collagen technology
Limit uncertainty with a leader in collagen technology Integra Dermal Regeneration Template PriMatrix Dermal Repair Scaffold A Pioneer in Regenerative Medicine Integra LifeSciences, a wordwide leader in
More informationSarah Medrano, RN, BSN, WOCN; and Mary Jo Beneke, RN, BS, CWOCN Yuma Regional Medical Center, Yuma, Arizona
Sound Evidence coustic Pressure Wound Therapy to ebride Unstageable Pressure Ulcers in the cute Care Setting: Case Series Sarah Medrano, RN, BSN, WCN; and Mary Jo Beneke, RN, BS, CWCN Yuma Regional Medical
More informationUse of an Acellular Regenerative Tissue Matrix Over Chronic Wounds
Use of an Acellular Regenerative Tissue Matrix Over Chronic Wounds D. Heath Stacey, MD Northwest Arkansas Center for Plastic Surgery, Fayetteville, Ark Correspondence: dheathstacey@gmail.com Keywords:
More informationPFIZER INC. PROPRIETARY DRUG NAME /GENERIC DRUG NAME: Cerebyx / Fosphenytoin Sodium
PFIZER INC These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationAcute and Chronic WOUND ASSESSMENT. Wound Assessment OBJECTIVES ITEMS TO CONSIDER
WOUND ASSESSMENT Acute and Chronic OBJECTIVES Discuss classification systems and testing methods for pressure ulcers, venous, arterial and diabetic wounds List at least five items to be assessed and documented
More informationThermal Dermal Burn Modeling in Rats and Minipigs
Thermal Dermal Burn Modeling in Rats and Minipigs Comparative Biosciences, Inc. 786 Lucerne Drive Sunnyvale, CA 94085 Telephone: 408.738.9261 www.compbio.com Premier Preclinical Contract Research Organization
More informationAlternative Pharmacological Management of Vasopressor Extravasation in the Absence of Phentolamine
Alternative Pharmacological Management of Vasopressor Extravasation in the Absence of Phentolamine Michelle Plum, PharmD; and Oussayma Moukhachen, PharmD, BCPS ABSTRACT Vasopressor extravasation is a rare
More informationCASE REPORT Use of a Hydroconductive Dressing to Treat a Traumatic Avulsive Injury of the Face
CASE REPORT Use of a Hydroconductive Dressing to Treat a Traumatic Avulsive Injury of the Face Colin Jerome Perumal, BDS, a and Martin Robson, MD b a Department of Maxillofacial and Oral Surgery, Medical
More informationTopical antimicrobials (antiseptics) Iodine, Silver, Honey
Topical antimicrobials (antiseptics) Iodine, Silver, Honey Iodine Honey Silver Enzymatic debridement Proteolytic enzyme, also called Proteinase Proteinase breaks the long chainlike molecules of proteins
More informationSOUTHERN WEST MIDLANDS NEWBORN NETWORK
SOUTHERN WEST MIDLANDS NEWBORN NETWORK Hereford, Worcester, Birmingham, Sandwell & Solihull Title : Person Responsible for Review : Management of Gastro-Intestinal Stomata In Neonates R. Wragg & G.Jawaheer
More informationYUJI YAMAGUCHI Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences
Nagoya Med. J., 149 Current status of regenerative medicine through the treatment for intractable skin wounds YUJI YAMAGUCHI Department of Geriatric and Environmental Dermatology, Nagoya City University
More informationChapter 23 Caring for Clients with Burns
Chapter 23 Caring for Clients with Burns Burn Injuries 4500 people die from burns each year High risk group ~ children and the elderly The most common cause of burns Smoking material Scalding Lighting
More informationMedical APMLE. Podiatry and Medical.
Medical APMLE Podiatry and Medical http://killexams.com/exam-detail/apmle Question: 290 Signs and symptoms of hemolytic transfusion reactions include: A. Hypothermia B. Hypertension C. Polyuria D. Abnormal
More information